On June 10, Lung Fung Group rose 8.46% in regular trading, trading at 2.94 HKD/share, with trading volume of approximately 22.76 million HKD. The stock extended the prior session's rebound momentum following a severe post-IPO selloff.

Lung Fung Group listed on June 5 at an offer price of 5.18 HKD and immediately collapsed, closing down 45.75% at 2.81 HKD on day one. On its second trading day, the stock hit a low of 2.45 HKD, representing a decline of over 50% from the IPO price. The extreme short-term oversold condition has triggered a sustained technical recovery over consecutive sessions.

On the news front, on June 8 the company's controlling shareholder deposited 375 million shares (representing 75% of total shares) into DBS Bank Hong Kong, with a deposited market value of approximately 1.054 billion HKD. This lock-up action by the major shareholder has provided some support to market sentiment. The IPO had no cornerstone investors, and international placement was only 3.18 times subscribed, contributing to initial selling pressure.

Lung Fung Group is Hong Kong's third-largest beauty, health, and pharmaceutical retailer, currently operating 31 stores. For fiscal year 2025, the company reported revenue of 2.46 billion HKD and net profit of 170 million HKD, with a revenue CAGR of 50%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)